ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 985

Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool with or without a Health Educator for Knowledge of RA Risk Factors

Maria G. Prado1, Rachel Miller Kroouze1, Zhi Yu1, Maura D. Iversen2,3,4, Nellie A. Triedman1, Sarah S. Kalia5, Kevin D. Deane6, Karen H. Costenbader1, Bing Lu1, Robert C. Green5, Elizabeth W. Karlson1 and Jeffrey A. Sparks7, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden, 3Physical Therapy, Movement and Rehabilitation Sciences, Northeastern University, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: family studies, genetics, Personalized Medicine, rheumatic education and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Much progress has been made in identifying risk factors for RA, but it is unclear whether individuals at risk for RA have knowledge of these factors. Potential educational interventions include reading materials, interactive web-based tools, and sessions with health educators. We assessed the effect of these educational interventions on RA risk factor knowledge among first-degree relatives (FDRs) of patients with RA using a randomized controlled trial.

Methods: We developed a web-based tool, the Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA), which collects data on an individual’s age, sex, family history, and risk-related behaviors; presents genetic and autoantibody results; displays relative risk and absolute risk of RA; and provides personalized education about RA risk. We randomly assigned FDRs without RA to 1 of 3 educational interventions: 1) Control group that received standard education about RA (n=80), 2) PRE-RA group that received personalized education via the web-based PRE-RA tool (n=80), and 3) PRE-RA Plus group that received PRE-RA and a one-on-one session with a health educator (n=78). We assessed RA knowledge at baseline and immediately, 6 weeks, and 6 months after education using the validated Illness Perception Questionnaire modified for RA. We calculated an RA knowledge score by summing the number of 8 RA risk factors that a subject agreed were related to RA. We used linear regression to compare RA knowledge scores from PRE-RA and PRE-RA Plus vs. controls at each time point adjusted for baseline score. We additionally evaluated the impact of the health educator in PRE-RA Plus vs. PRE-RA alone at each post-intervention time point as well as change in RA knowledge compared to baseline.

Results: Among 238 randomized FDRs at baseline, mean age was 45.6 years (SD 14.4), 76% were female, 88% were college educated, and mean RA knowledge score (possible range 0-8) was 4.3 (SD 1.9). At baseline, only 31% agreed smoking was a risk factor for RA, but this increased to 77% at 6 months after PRE-RA (p<0.001). Those who received PRE-RA or PRE-RA Plus had higher mean RA knowledge scores immediately (7.1 [SD 1.0]) and 6 months (6.3 [SD 1.6]) after personalized education compared to controls (immediate 5.3 [SD 1.7] and 6 months 4.8 [SD 2.0); p<0.001, Figure). Compared to only the PRE-RA tool, those who also met with a health educator had similar RA knowledge 6 months after education (improvement of 1.7 [SD 1.8] for PRE-RA; 2.4 [SD 1.9] for PRE-RA Plus, p=0.16).

Conclusion: Despite being both familiar with and at increased risk for RA, FDRs had low baseline knowledge about RA risk factors. We created an interactive, web-based personalized tool that educated FDRs about RA, and this increased knowledge persisted for 6 months. While there may be some additional benefit by also using a health educator, the PRE-RA tool alone is an effective method to educate individuals about RA risk factors to encourage positive health behaviors.


Disclosure: M. G. Prado, None; R. Miller Kroouze, None; Z. Yu, None; M. D. Iversen, None; N. A. Triedman, None; S. S. Kalia, None; K. D. Deane, Inova Diagnostics, Inc., 9; K. H. Costenbader, UpToDate, 7; B. Lu, None; R. C. Green, Invitae, 5,Prudential, 5,Illumina, 5,AIA, 5,Helix, 5,Roche Pharmaceuticals, 5; E. W. Karlson, None; J. A. Sparks, None.

To cite this abstract in AMA style:

Prado MG, Miller Kroouze R, Yu Z, Iversen MD, Triedman NA, Kalia SS, Deane KD, Costenbader KH, Lu B, Green RC, Karlson EW, Sparks JA. Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool with or without a Health Educator for Knowledge of RA Risk Factors [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/effectiveness-of-a-web-based-personalized-rheumatoid-arthritis-risk-tool-with-or-without-a-health-educator-for-knowledge-of-ra-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-a-web-based-personalized-rheumatoid-arthritis-risk-tool-with-or-without-a-health-educator-for-knowledge-of-ra-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology